Skip to Main Content

The Three Column People Listing

Description:

This layout view displays the faculty members in a single columned table. Use this view to display a limited amount of information for a faculty listing containing a relatively small number of faculty members.
  • Assistant Professor of Clinical Psychiatry; Clinical Psychologist, Psychology Section

    Caroline Schmidt is a clinical psychologist who offers patients streamlined access to culturally affirmative mental health care that is integrated within the patients' medical home using a Collaborative Care Management model. Currently her services are only available through referral by Yale Internal Medicine Associates providers. Patients with depression or anxiety may engage in brief, team-based care, which includes supportive psychotherapy and medication management.

    Much of Dr. Schmidt’s training and background are in Health Psychology, a field that treats mental health issues that co-occur with or impact physiological health conditions. “It’s not uncommon when people have some sort of health problem that they also need some support for their emotional needs,” says Dr. Schmidt. “When you use a team approach to incorporate the mind and body together in treatment, it’s very helpful for patients.” As a clinician, Dr. Schmidt prides herself offering compassionate support for people as they implement changes to recover from and prevent these distressing conditions.

    In addition to seeing patients, Dr. Schmidt is an assistant clinical professor in the Department of Psychiatry at the Yale School of Medicine.

  • Associate Professor Adjunct of Psychiatry; Deputy Director for Research, and Director of Neuroimaging, Clinical Neuroscience Division, VA National Center for PTSD

    Dr. Chadi G. Abdallah has expertise in antidepressants clinical trials, translational clinical neuroscience, multimodal neuroimaging, and the development of rapid acting antidepressant for the treatment of depression, PTSD and other stress-related psychiatric disorders. He employs broad range of pharmacological challenges, neuroimaging modalities, and network neuroscience approaches to study the neurobiology of depression and other psychiatric disorders and the mechanisms underlying treatment response and resistance. His research program focuses on understanding the mechanisms underlying trauma, depression, and chronic stress, with emphasis on the role of synaptic connectivity and neuroenergetics.

  • Associate Professor of Psychiatry

    Research Interests
    • Behavioral Sciences
    • Electrochemistry
    • Neurobiology
    • Psychiatry
    • Signal Transduction
    • Substance-Related Disorders

    Nii Addy is an Associate Professor of Psychiatry and of Cellular and Molecular Physiology. He received his B.S. in Biology from Duke University and his Ph.D. in Neuroscience from Yale University. Dr. Addy directs a federally funded research program investigating cholinergic, dopaminergic and L-type calcium channel mechanisms mediating substance use and mood disorders. Dr. Addy’s team also studies the ability of tobacco product flavor additives to alter nicotine use behavior and addiction. He serves on the journal editorial board of Neuropsychopharmacology, Biological PsychiatryNicotine & Tobacco Research, and Neuropharmacology, and is a grant reviewer for the Neurobiology of Motivated Behavior (NMB) Study Section of the National Institutes of Health's Center for Scientific Review (CSR). Dr. Addy currently serves as the inaugural Director of Scientist Diversity and Inclusion at the Yale School of Medicine, as the Director of the faculty mentoring program for the Yale Minority Organization for Retention and Expansion (MORE), and as Co-chair of the Career Development Subcommittee of the Anti-Racism Task Force in the Yale Department of Psychiatry. He also contributes to graduate student and postdoctoral training and to diversity, equity, and inclusion initiatives through his efforts on campus and in scientific societies.

    In addition to his campus work, Dr. Addy hosts the Addy Hour podcast, discussing topics at the intersection of neuroscience, mental health, faith, culture and social justice. Episodes include dynamic conversations based on the lived experience and professional expertise of his guests - which include community leaders, clinicians and mental health experts, scientists, professional athletes and entertainers, faith leaders, and mental health advocates. As the creator and host of town hall community events, Dr. Addy has also built unique partnerships to encourage and equip audiences to embrace the use of holistic, integrated tools to address mental health challenges. He has collaborated with Lecrae (Grammy Award-winning artist and NY Times Best Seller), Doug Middleton (Jacksonville Jaguars/ Dream the Impossible Initiative), Allan Houston (former NBA All-Star, NY Knicks/ FISLL Project), the National Alliance on Mental Illness (NAMI), the Veritas Forum, the Anxiety and Depression Association of America (ADAA), the Association for Behavioral and Cognitive Therapies (ABCT), the Yale University Chaplain's Office, Yale Well, the Salvation Army, Every Nation Church NYC, the American Bible Society and others. His research and community work have been featured by National Public Radio (NPR), Newsday, the National Football League Players Association (NFLPA), The Source Magazine, Chuck Norris, BoldTV, Legitimate Matters, and Relevant Magazine. He has presented scientific lectures at universities throughout the United States and Europe, and he serves on the Board of Trustees for The Carver Project, aimed at empowering and connecting individuals across university, church and society.

  • Associate Professor of Psychiatry and of Neuroscience; Director, Minority Recruitment, Psychiatry Department; Director, Postdoctoral Affairs, Psychiatry Department

    Research Interests
    • Acetylcholine
    • Electrophysiology
    • Glutamates
    • Interneurons
    • Memory
    • Neurobiology
    • Nicotine
    • Psychiatry
    • Puberty
    • Signal Transduction
    • Prefrontal Cortex
    • Kisspeptins
  • Associate Professor of Neurology and of Psychiatry; Track Director, Health Informatics, Online Executive MPH Program

    Research Interests
    • Brain Injuries
    • Epilepsy
    • Medical Informatics
    • Health Care Quality, Access, and Evaluation
    • Psychiatry and Psychology

    Dr. Altalib is the Director of the Veteran Administration (VA) Epilepsy Center of Excellence in West Haven, CT, where he oversees and provides direct care for Veterans with epilepsy throughout the greater New England region. He helped established a VA Neurobehavioral clinic, which provides clinical care for Veterans who suffer from emotional distress and/or behavioral problems associated with neurological conditions (such as traumatic brain injury, stroke, and epilepsy). At Yale University he also provides care for people with neurological injury that impact emotional processing. For instance, epilepsy, traumatic brain injury, movement disorders (and their treatments) can affect brain circuits and chemistry and lead to mood, anxiety, and even psychotic disorders. Furthermore, neuropsychiatric conditions such functional movement disorder and psychogenic non-epileptic seizures are managed in his clinic.

    Dr. Altalib is also the Director of the Yale Epilepsy Outcomes Research Program, in which he oversees clinical trials and cohort studies related to epilepsy interventions. In addition to seizure control outcomes, his research explores psychiatric co-morbidity of neurologic disease. He is currently the primary investigator of a studies examining the neurologic substrates of depression in people with epilepsy; the burden of psychogenic non-epileptic seizures in the Veteran population; and measuring coordination of health care using social network analysis methods.

  • Assistant Professor of Clinical Psychiatry; Director, Yale Cocaine Research Clinic, Psychiatry; Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU), Psychiatry; Medical Director, Forensic Drug Diversion Clinic (ForDD)

    Experiencing the impact of the cocaine epidemic in my native Colombia led me to pursue a career dedicated to the improved understanding and treatment of cocaine addiction. Since completing Clinical Training and becoming U.S Board Certified in Adult Psychiatry and Addictions Psychiatry in 2012, I have developed academic interest in the regulation of cocaine self-administration in humans, the validation of Remote Wireless Sensor Network (RWSN) technology for detecting cocaine use, and the role of cocaine-induced deficits in sleep in the putative therapeutic effects of the atypical stimulant, modafinil. Currently; my main career interests lie in the development of neurobiologically informed medication treatments for cocaine dependence, such as the ones based on homeostatic changes on the glutamatergic pathways. As Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU) of the Connecticut Mental Health Center (CMHC), I provide care for the patients who are admitted on our floor in order to participate in research studies or in order to receive treatment for the psychiatric conditions afflicting them. This setting fosters collaboration with other clinicians, researchers, as well as teaching of Medical Students and Psychiatry Residents

  • Associate Professor of Psychiatry; Director, Adult Refugee clinic; Director, Wellness Center, Connecticut Mental Health Center

    Research Interests
    • Refugees
    • Diseases
    • Psychiatry and Psychology
    • Health Care

    My training was in a dual Internal Medicine/Psychiatry residency program. My clinical interests are in providing care to patients with both medical and mental health problems. My academic interests are in integrating primary care and mental health services. Two populations I work with are refugees and people with serious mental illness. I strongly believe that students and residents in any discipline should be well trained in both physical and mental aspects of illness enabling them to have a holistic approach to patient care.

  • Associate Professor of Psychiatry; Director, Division of Neurocognition, Neurocomputation, and Neurogenetics (N3), Psychiatry

    Research Interests
    • Affect
    • Mental Disorders
    • Cognition
    • Diagnosis, Computer-Assisted
    • Emotions
    • Memory, Short-Term
    • Schizophrenia
    • Computational Biology
    • Substance-Related Disorders
    • Neuroimaging

    Dr. Anticevic trained in Clinical Psychology and Cognitive Neuroscience at Washington University in St. Louis where he trained with Drs. Deanna Barch and David Van Essen. Following graduate training, Dr. Anticevic completed his internship in Clinical Neuropsychology at Yale University. After internship, he joined the Yale University Department of Psychiatry as research faculty while concurrently serving as the Administrative Director for the Center for the Translational Neuroscience of Alcoholism. Subsequently, he was appointed as an Assistant Professor of Psychiatry and Psychology at the Yale University School of Medicine, where he directs a clinical neuroimaging laboratory focused on severe mental illness. Dr. Anticevic is a recipient of the NARSAD Young Investigator Award, the International Congress of Schizophrenia Research Young Investigator Award, the NIH Director's Early Independence Award, the NARSAD Independent Investigator Award and the Klerman Prize for Exceptional Clinical Research. He currently serves as the Director of the Division of Neurocognition, Neurocomputation, and Neurogenetics (N3) at Yale School of Medicine.

    His group's research focus is centered on computational and cognitive neuroscience of mental illness. Specifically, Dr. Anticevic's group is interested in characterizing neural mechanisms involved in higher order cognitive operations, such as working memory, as well as their interaction with neural systems involved in affective processes, with the aim of understanding how these computations may go awry in the context of severe mental illness . Methodologically, his group uses the combination of task-based, resting-state, pharmacological multi-modal neuroimaging, as well as computational modeling approaches to map neural alterations that lead to poor mental health outcomes. The overarching goal of the group is to develop neurobiologically principled and computationally grounded mapping between neural and behavioral levels of analyses in people to inform personalized and rational treatment design for mental health symptoms.

  • Albert E. Kent Professor of Neuroscience and Professor of Psychology; Member, Kavli Institute of Neuroscience at Yale University

    Research Interests
    • Aging
    • Alzheimer Disease
    • Behavioral Sciences
    • Psychology, Child
    • Mental Health
    • Neurobiology
    • Neurosciences
    • Stress Disorders, Post-Traumatic
    • Prefrontal Cortex
    • Cognitive Science

    Dr. Arnsten is an international expert on the molecular regulation of higher cortical circuits, and a member of the National Academy of Medicine. She received her B.A. in Neuroscience from Brown University in 1976 (where she created the Neuroscience major), and her Ph.D. in Neuroscience from UCSD in 1981. She did post-doctoral research with Dr. Susan Iversen at Cambridge University in the UK, and with Dr. Patricia Goldman-Rakic at Yale. Dr. Arnsten's research examines the neural basis of higher cognition. Her work has revealed that the newly evolved cortical circuits that underlie higher cognition are uniquely regulated at the molecular level, conferring vulnerability in mental illness and age-related cognitive disorders such as Alzheimer's Disease. Arnsten's research has led to new treatments for cognitive disorders in humans, including the successful translation of guanfacine (IntunivTM) for the treatment of ADHD and related prefrontal cortical disorders.

  • Associate Professor of Psychiatry; Director of Dialectical Behavior Therapy Services, Yale-New Haven Psychiatric Hospital Intensive Outpatient Program; Director of Yale Instruction/Investigation/Intervention in Emotional Lability and Dysregulation (YIELD)

    Research Interests
    • Behavior Therapy
    • Borderline Personality Disorder
    • Burnout, Professional
    • Psychiatry
    • Stress Disorders, Post-Traumatic
    • Substance Abuse Detection
    • Mindfulness

    I am very interested in training clinicians in personality disorders and dialectical behavior therapy (DBT). I am particularly interested in helping therapists observe personal limits to improve treatment alliance, therapy effectiveness, and therapist satisfaction, and to reduce therapist burnout. In addition to my work at Yale, I am a trainer/consultant with Behavioral Tech, LLC, an organization developed by Dr. Marsha Linehan to disseminate DBT and other empirically supported therapies. Each spring I co-chair a conference on Borderline Personality Disorder in partnership with the National Education Alliance for BPD and co-provided by the Yale School of Medicine, Yale New Haven Psychiatric Hospital, and the Yale Stress Center.

  • Professor of Psychiatry; Associate Dean for Faculty Affairs, Dean's Office; Deputy Chair for Career Development, Psychiatry

    Research Interests
    • Behavior and Behavior Mechanisms
    • Mental Disorders
    • Homeless Persons
    • Personality
    • Personality Disorders
    • Psychiatry
    • Psychotherapy
    • Substance Abuse Detection
    • Treatment Outcome
    • Psychiatry and Psychology

    I am involved in the coordination of faculty development both within the Department of Psychiatry and in Yale School of Medicine with a focus of working with non-procedural and bridge departments. I have served in several research, education, and clinical leadership positions in the Department of Psychiatry and affiliated non-profit clinical, research, and policy organizations including The APT Foundation, Silver Hill Hospital, and The National Center of Addiction and Substance Abuse. I direct the faculty reappointment and promotion processes in my department and am involved in the development and evaluation of medical school-wide junior faculty mentoring programs. I am a trained mentor and professional coach and consult with junior faculty and departmental leaders on: promotion processes and readiness; incorporation into academic review processes improved assessments of clinical and educational excellence, professionalism, and diversity and inclusion activities, and; consultation on matters related to professional stress, burnout, and impairment. My clinical expertise is the treatment of patients with addiction and co-occurring personality disorders, and I have developed and conducted clinical trials on a specialized psychotherapy for these complex patients and founded a specialized residential treatment program for high functioning professionals (particularly physicians and attorneys) and executives suffering from these disorders. During the COVID-19 pandemic, I  developed and directed a 1:1 professional support provider services program for Yale  Medicine and Yale New Haven Health healthcare workers and their families.

  • Associate Professor of Psychiatry; Director of Pain Treatment Services, APT Foundation; Director of Research, APT Foundation

    Research Interests
    • Culture
    • Opioid-Related Disorders
    • Psychotherapy
    • Substance-Related Disorders
    • Chronic Pain
    • Psychiatry and Psychology

    Dr. Barry is a licensed clinical psychologist and an Associate Professor in the Department of Psychiatry and in the Child Study Center at Yale School of Medicine. He is Research Director at the APT Foundation, Inc., a not-for-profit community based organization affiliated with Yale that is one of the largest providers of medication for opioid use disorder in Southern New England. He is the Founding Director of the APT Foundation Pain Treatment Services, a research-based training clinic that offers interdisciplinary treatment to individuals with chronic pain and opioid use disorder, including cognitive-behavioral therapy, exercise-based interventions, complementary and integrative health approaches, and pharmacotherapy.

    Dr. Barry has trained and supervised Yale psychiatry, psychology, and nursing fellows; physician associates; and social workers, as well as non-Yale interns from master’s counseling programs on interdisciplinary treatment approaches for chronic pain and opioid use disorder.

    His  research is aimed at: 

    1. Developing and evaluating treatments for co-occurring opioid use disorder and chronic pain.
    2. Examining the role of sociocultural, psychological, and biologic al factors in the occurrence and treatment of pain and addictions. 

    Dr. Barry has published over one hundred peer-reviewed articles. He is currently a multiple principal investigator on 2 NIH funded studies (U01 HL150596-01 and RM1 DA055310-01).

    Dr. Barry is Associate Editor of the Journal of Immigrant and Minority Health and is Co-Editor of the Substance Use Disorder Section at Pain Medicine.



  • Associate Professor Term

    Dr. Arielle Baskin-Sommers is a licensed clinical psychologist. She received her Sc.B. from Brown University (2007), a Ph.D. from the University of Wisconsin-Madison (2013), and completed her pre-doctoral internship and fellowship at McLean Hospital/Harvard Medical School. Substantively, her research is concentrated on understanding individual differences in cognitive and affective processes as they relate to vulnerability for disinhibitory psychopathology. Methodologically, she is interested in integrating a wide range of techniques and technologies to explore this issue. Overall, her professional career goals are based on a desire to develop both innovative theory and research in service of increasing the efficacy of clinical intervention.

  • Assistant Professor of Psychiatry

    Anahita Bassir Nia, MD, joined Yale School of Medicine in July 2018 as Assistant Professor of Psychiatry, after completing her psychiatry residency at Mount Sinai Beth Israel, and her addiction psychiatry fellowship-academic track at Mount Sinai West, Icahn School of Medicine, New York.

    Her research interests are, mainly, in translational research on addiction and mental health disorders. She is particularly interested in the biological effects of acute and chronic stress on developing substance use disorders, as well as, the effects of substance use on stress response and psychiatric symptoms. More recently, she has been focused on the use of cannabinoids (partial and full agonists) and endocannabinoid system dysregulations in relation to childhood trauma and substance use disorders, particularly opioid use disorder. 

  • Harold W. Jockers Associate Professor of Medical Education and Associate Professor of Psychiatry; Associate Deputy Dean for Education, Medical Education

    Dr. Richard Belitsky, Harold W. Jockers Associate Professor of Medical Education and Associate Professor of Psychiatry, is noted for his work in medical education at both the undergraduate (medical student) and graduate (resident) levels.

    Named the School of Medicine’s deputy dean for education in 2006, Dr. Belitsky is concerned with curriculum development, particularly with respect to the methods and challenges involved in teaching medical students in the areas of patient-centered medical interviewing, the biopsychosocial model, social history and counseling patients for behavior change. He is also interested in the development of professional identity in medical education. In addition, he is interested in the delivery of mental health services in prisons and jails, with particular attention to suicide in correctional facilities.

    Belitsky holds a B.A. from the University of Florida, Gainesville, and an M.D. from the University of Florida School of Medicine. He came to Yale in 1979 as a resident in psychiatry and continued on as a fellow in forensic psychiatry and chief resident/instructor in the Department of Psychiatry. He joined the faculty as an assistant professor in 1983, when he also became unit chief of the Inpatient Services Division of the Connecticut Mental Health Center. He served as the director of the division 1988-1989. He was the medical director of the Yale Psychiatric Institute 1991-1997.

    At the School of Medicine, Belitsky has served as the residency program director in the Department of Psychiatry 1996-2006. He became the deputy chair for education in 2001, serving in that role until he was promoted to deputy dean for education. He has earned numerous professional honors at Yale, including the Stephen Fleck M.D. Faculty Award as Exemplary Physician and Teacher, the Charles W. Bohmfalk Teaching Prize and the Francis Gilman Blake Award (for the member of the faculty at the School of Medicine designated by the senior class as the most outstanding teacher of the medical sciences) in both 1998 and 2000.